These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 1384920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE.
    J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G, Heyns CF, Allen FJ.
    Eur Urol; 1999 Feb; 35(3):223-7. PubMed ID: 10072624
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA, Valenzuela H, Morote J, Gelabert A.
    Eur J Nucl Med; 1999 Jun; 26(6):625-32. PubMed ID: 10369948
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L, Adjinovic B, Cerovic S, Joksimovic M, Soldatovic Z.
    Hell J Nucl Med; 2011 Jun; 14(2):126-30. PubMed ID: 21761013
    [Abstract] [Full Text] [Related]

  • 12. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.
    Huncharek M, Muscat J.
    Abdom Imaging; 1996 Jun; 21(4):364-7. PubMed ID: 8661585
    [Abstract] [Full Text] [Related]

  • 13. Procollagen type I carboxyterminal extension peptide in serum: a reliable marker of bone metastatic disease in newly diagnosed prostate cancer?
    Perachino M, Di Ciolo L, Barbetti V, Puppo P.
    Eur Urol; 1996 Jun; 29(3):366-9. PubMed ID: 8740025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD.
    Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV, Bennett A, Narahari K, Hughes O, Rees J, Kynaston H.
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [Abstract] [Full Text] [Related]

  • 20. Retrospective study of predictors of bone metastasis in prostate cancer cases.
    Ho CC, Seong PK, Zainuddin ZM, Abdul Manaf MR, Parameswaran M, Razack AH.
    Asian Pac J Cancer Prev; 2013 Nov; 14(5):3289-92. PubMed ID: 23803117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.